|
1
|
Yunos NM, Kim IB, Bellomo R, Bailey M, Ho
L, Story D, Gutteridge GA and Hart GK: The biochemical effects of
restricting chloride-rich fluids in intensive care. Crit Care Med.
39:2419–2424. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Smith RJ, Reid DA, Delaney EF and
Santamaria JD: Fluid therapy using a balanced crystalloid solution
and acid-base stability after cardiac surgery. Crit Care Resusc.
12:235–241. 2010.PubMed/NCBI
|
|
3
|
Yunos NM, Bellomo R, Story D and Kellum J:
Bench-to-bedside review: Chloride in critical illness. Crit Care.
14:2262010. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wilcox CS: Regulation of renal blood flow
by plasma chloride. J Clin Invest. 71:726–735. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bullivant EM, Wilcox CS and Welch WJ:
Intrarenal vasoconstriction during hyperchloremia: Role of
thromboxane. Am J Physiol. 256:F152–F157. 1989.PubMed/NCBI
|
|
6
|
Williams EL, Hildebrand KL, McCormick SA
and Bedel MJ: The effect of intravenous lactated Ringer's solution
versus 0.9% sodium chloride solution on serum osmolality in human
volunteers. Anesth Analg. 88:999–1003. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wilkes NJ, Woolf R, Mutch M, Mallett SV,
Peachey T, Stephens R and Mythen MG: The effects of balanced versus
saline-based hetastarch and crystalloid solutions on acid-base and
electrolyte status and gastric mucosal perfusion in elderly
surgical patients. Anesth Analg. 93:811–816. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chowdhury AH, Cox EF, Francis ST and Lobo
DN: A randomized, controlled, double-blind crossover study on the
effects of 2-L infusions of 0.9% saline and plasma-lyte®
148 on renal blood flow velocity and renal cortical tissue
perfusion in healthy volunteers. Ann Surg. 256:18–24. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chowdhury AH, Cox EF, Francis ST and Lobo
DN: A randomized, controlled, double-blind crossover study on the
effects of 1-L infusions of 6% hydroxyethyl starch suspended in
0.9% saline (voluven) and a balanced solution (Plasma Volume
Redibag) on blood volume, renal blood flow velocity, and renal
cortical tissue perfusion in healthy volunteers. Ann Surg.
259:881–887. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yunos NM, Bellomo R, Glassford N,
Sutcliffe H, Lam Q and Bailey M: Chloride-liberal vs.
chloride-restrictive intravenous fluid administration and acute
kidney injury: an extended analysis. Intensive Care Med.
41:257–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yunos NM, Bellomo R, Hegarty C, Story D,
Ho L and Bailey M: Association between a chloride-liberal vs
chloride-restrictive intravenous fluid administration strategy and
kidney injury in critically ill adults. JAMA. 308:1566–1572. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bellomo R, Ronco C, Kellum JA, Mehta RL
and Palevsky P: Acute Dialysis Quality Initiative workgroup: Acute
renal failure - definition, outcome measures, animal models, fluid
therapy and information technology needs: the Second International
Consensus Conference of the Acute Dialysis Quality Initiative
(ADQI) Group. Crit Care. 8:R204–R212. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stevens PE and Levin A: Kidney Disease:
Improving Global Outcomes Chronic Kidney Disease Guideline
Development Work Group Members: Evaluation and management of
chronic kidney disease: synopsis of the kidney disease: improving
global outcomes 2012 clinical practice guideline. Ann Intern Med.
158:825–830. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Singbartl K and Kellum JA: AKI in the ICU:
Definition, epidemiology, risk stratification, and outcomes. Kidney
Int. 81:819–825. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Paudel MS, Wig N, Mahajan S, Pandey RM,
Guleria R and Sharma SK: A study of incidence of AKI in critically
ill patients. Ren Fail. 34:1217–1222. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Uchino S, Kellum JA, Bellomo R, Doig GS,
Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, et al:
Beginning and Ending Supportive Therapy for the Kidney (BEST
Kidney) Investigators: Acute renal failure in critically ill
patients: A multinational, multicenter study. JAMA. 294:813–818.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Odutayo A, Adhikari NK, Barton J, Burns
KE, Friedrich JO, Klein D, Lapinsky S, Litwin S, Meret A, Moineddin
R, et al: Epidemiology of acute kidney injury in Canadian critical
care units: A prospective cohort study. Can J Anaesth. 59:934–942.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Negi S and Shigematsu T: Current
therapeutic strategies for acute kidney injury. Clin Exp Nephrol.
16:672–678. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin YF, Ko WJ, Chu TS, Chen YS, Wu VC,
Chen YM, Wu MS, Chen YW, Tsai CW, Shiao CC, et al: NSARF Study
Group: The 90-day mortality and the subsequent renal recovery in
critically ill surgical patients requiring acute renal replacement
therapy. Am J Surg. 198:325–332. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsagalis G: Update of acute kidney injury:
Intensive care nephrology. Hippokratia. 15(Suppl 1): 53–68.
2011.PubMed/NCBI
|
|
21
|
Shaw AD, Bagshaw SM, Goldstein SL, Scherer
LA, Duan M, Schermer CR and Kellum JA: Major complications,
mortality, and resource utilization after open abdominal surgery:
0.9% saline compared to Plasma-Lyte. Ann Surg. 255:821–829. 2012.
View Article : Google Scholar : PubMed/NCBI
|
